Recommendations for the Registration of Agents to be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science.

MLA

Abadie, Eric C., et al. “Recommendations for the Registration of Agents to Be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science.” Seminars in Arthritis & Rheumatism, vol. 35, no. 1, Aug. 2005, pp. 1–4. EBSCOhost, https://doi.org/10.1016/j.semarthrit.2005.03.006.

APA

Abadie, E. C., Devogealer, J.-P., Ringe, J. D., Ethgen, D. J., Bouvenot, G. M., Kreutz, G., Laslop, A., Orloff, J. J., Vanderauwera, P. M., Delmas, P. D., Dere, W. H., Branco, J., Altman, R. D., Avouac, B. P., Menkes, C. J., Vanhaelst, L., Mitlak, B. H., Tsouderos, Y., & Reginster, J.-Y. L. (2005). Recommendations for the Registration of Agents to be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science. Seminars in Arthritis & Rheumatism, 35(1), 1–4. https://doi.org/10.1016/j.semarthrit.2005.03.006

Chicago

Abadie, Eric C., Jean-Pierre Devogealer, Johann D. Ringe, Dominique J. Ethgen, Gilles M. Bouvenot, Gottfried Kreutz, Andrea Laslop, et al. 2005. “Recommendations for the Registration of Agents to Be Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Updated Recommendations from the Group for the Respect of Ethics and Excellence in Science.” Seminars in Arthritis & Rheumatism 35 (1): 1–4. doi:10.1016/j.semarthrit.2005.03.006.